Patent approved for UNE researcher’s innovative breast cancer detection and monitoring method

September 21, 2018

Mohan received the patent for his research, which uses a marker in the blood to detect the presence of highly aggressive tumors and to help track cancer growth.

(Reprint from Journal Tribune 9/20/2018) BIDDEFORD – The United States Patent and Trademark Office has issued a patent to Dr. Srinidi Mohan, an associate professor in the University of New England College of Pharmacy, for his methods and diagnostics for cancer detection and treatment monitoring. Read more here.